The Biomarkers Consortium: on the critical path of drug discovery

Clinical Pharmacology and Therapeutics
C A Altar

Abstract

Recent advances in science have provided a variety of genetic, genomic, and protein-based methods to treat human diseases. These advances, and equally great strides in in vivo imaging and methods of tissue collection, have created an unprecedented opportunity to discover and develop biological markers of human disease. A biomarker is defined as a molecular, biological, or physical characteristic that indicates a specific physiologic state (see Table 1 for definitions). It is used in clinical practice to identify risk for disease, diagnose disease and its severity, guide intervention strategies, and monitor patient responses to therapy. When used in a clinical research setting, biomarkers may predict whether a drug or other intervention is safe and effective in a shorter time and at lower cost than clinical outcomes studies. For these and other reasons, including the ability to stratify patient groups based on objective criteria, biomarkers help promote regulatory approval of new therapeutic entities by pharmaceutical, biological, and device development teams.

References

Mar 10, 2001·Clinical Pharmacology and Therapeutics·UNKNOWN Biomarkers Definitions Working Group.
Feb 7, 2004·European Journal of Endocrinology·José Manuel Fernández-RealWifredo Ricart
Jun 26, 2004·Stroke; a Journal of Cerebral Circulation·Tom JeerakathilCharles DeCarli
Apr 20, 2005·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Gary J KelloffDaniel C Sullivan
Oct 29, 2005·Nuclear Medicine and Biology·Wei ZhangHank F Kung
Jan 7, 2006·Pharmaceutical Research·Jean W LeeJohn A Wagner
Jan 30, 2007·Clinical Pharmacology and Therapeutics·J Woodcock
Mar 10, 2007·Nature Reviews. Drug Discovery·Leslie M ShawJohn Q Trojanowski
Apr 17, 2007·Biological Psychiatry·Thomas R Insel, Thomas Lehner

❮ Previous
Next ❯

Citations

Jul 4, 2012·Journal of Cardiovascular Translational Research·Helen D Nickerson, Sanjoy Dutta
Jun 18, 2011·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Daniel C DanilaHoward I Scher
Dec 20, 2012·BMC Medical Informatics and Decision Making·Erfan YounesiJuliane Fluck
Feb 9, 2012·Child and Adolescent Psychiatry and Mental Health·John S March, Joerg M Fegert
Apr 29, 2009·Clinical Chemistry and Laboratory Medicine : CCLM·Karin J VelthoveMadelon Bracke
Jun 10, 2011·International Journal of Environmental Research and Public Health·Paurene Duramad, Nina T Holland
Jun 27, 2012·Biomarkers in Medicine·Erik A B BuijsSaskia N de Wildt
Jun 27, 2014·Science Translational Medicine·Mark D Lim
Sep 18, 2015·Clinical Pharmacology and Therapeutics·G Lavezzari, A W Womack
Dec 17, 2010·Depression and Anxiety·John S March
Oct 25, 2013·International Review of Psychiatry·Gudrun HefnerChristoph Hiemke
Apr 24, 2015·Expert Review of Anticancer Therapy·Atiqullah AzizSabine Brookman-May
Sep 1, 2012·Biochemical Pharmacology·Diren Beyoğlu, Jeffrey R Idle
Aug 22, 2008·Clinical Pharmacology and Therapeutics·N PetrickK J Myers
Oct 21, 2009·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Aimery de GramontRichard L Schilsky
Oct 10, 2009·Drug Discovery Today·Salim Shah, Howard J Federoff
Apr 5, 2012·Clinical and Applied Thrombosis/hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis·Yu Chen BarrettRobert M Knabb
Nov 23, 2011·Biomarkers in Medicine·John A Wagner
Sep 21, 2013·Omics : a Journal of Integrative Biology·Oxana TrifonovaAlexander Archakov
Jan 19, 2008·Clinical Pharmacology and Therapeutics·J A Wagner
Apr 23, 2013·The Annals of Pharmacotherapy·Glenn Dexter O PebancoStuart T Haines
Dec 3, 2008·Abdominal Imaging·Bernard E Van Beers, Valérie Vilgrain
Apr 7, 2010·Nature Reviews. Clinical Oncology·Marc BuyseAimery de Gramont
Dec 18, 2010·Magyar onkologia·Róbert János BánhegyiBéla Pikó
Oct 28, 2009·Nature Reviews. Nephrology·Matthew P Welberry SmithPeter J Selby
Dec 8, 2014·Plant Foods for Human Nutrition·M Elena Díaz-RubioFulgencio Saura-Calixto
May 1, 2010·Insights Into Imaging·UNKNOWN European Society of Radiology (ESR)
Sep 1, 2009·Personalized Medicine·Christopher-Paul Milne
May 24, 2020·The Journal of Applied Laboratory Medicine·Jenna T ReeceLeslie M Shaw
Apr 22, 2010·Clinical Pharmacology and Therapeutics·J A Wagner
Apr 22, 2010·Clinical Pharmacology and Therapeutics·J A WagnerM T Vassileva
Aug 7, 2008·Analytical Chemistry·Viktor AdalsteinssonJong-in Hahm

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
Gary J KelloffJanet Woodcock
Disease Markers
Sandra C Kirkwood, Richard D Hockett
© 2021 Meta ULC. All rights reserved